Intellipharmaceutics International Inc. (IPCI)

[Samsa]

Tilator, I am not mixing the two. You absolutely have the same issues selling a generic as you do an NDA. You need personnel, networking and connections. sometimes its the connections more than anything else. in the generic space the only thing you have to offer is price. a lot of times that doesn't even get you the contract its your connections.

but you totally missed what the point was. The company screwed up by abandoning the original business model. they are not setup for distribution and manufacturing and sales. they never intended to be. the profit margin is small on generics anyway and is not much better on NDA's as then your costs go up exponentially. so they would have been better to go back to what they could have done best, which is the science. develop the drug and license and or partner it off and keep overhead low and just rake in profit.

the only reason this didn't work is Odidi's unwillingness to allow a partner to take control of his technology.